Merkel Positron Emission Tomography (PET) Protocol

Clinical trial NCT01013779 · COMPLETED

Trial details

NCT number: NCT01013779
Sponsor: Trans Tasman Radiation Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Merkel Cell Carcinoma

Start date: 2009-12-01
Primary completion: 2021-06-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.